Public Data
6 samples
Whole transcriptome sequencing for wild type and IRAIN over-expression K562 cells
Accession: SRP500740
Created: 2024
cell line
control, overexpression
blood
chronic myelogenous leukemia, BCR-ABL1 positive
Public Data
9 samples
Transcriptome comparison of monocytes, activated CD4 T cells, and activated CD8 T cells in healthy human peripheral blood
Accession: SRP500338
Created: 2024
primary cells
control, other
blood
Public Data
1 sample
Expression profile of urinary exosomal miRNAs in patients with diabetic kidney disease and their associated with kidney damage
Accession: SRP501500
Created: 2024
primary tissue
urine
diabetic kidney disease
Public Data
6 samples
DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [MDA]
Accession: SRP435622
Created: 2024
cell line
control, shrna
breast
breast cancer
Public Data
12 samples
DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [BT474]
Accession: SRP435623
Created: 2024
cell line
compound, control
breast
breast cancer
Public Data
12 samples
RNA-sequencing of primary human glioblastoma resected tissue before and after a personalized, neoantigen-based vaccine plus poly-ICLC (NeoVax); tissues from a Phase 1 clinical trial
Accession: SRP450776
Created: 2024
primary tissue
control, peptide or biologic
brain
glioblastoma
Public Data
36 samples
Enhancing Cell-Based Regenerative Therapies with Peptide-Modified Thermo-responsive Citrate-Based Biomaterials for Treatment of Critical Limb Ischemia
Accession: SRP500840
Created: 2024
cell line
compound
umbilical vein
Public Data
36 samples
RNA-seq of SKOV3 cell line
Accession: SRP422667
Created: 2024
cell line
compound, control, ...
ovary
ovarian cancer
Public Data
45 samples
Distinctive Transcriptional and Microbial Signature in Cutaneous Acute Graft-vs-Host-Disease
Accession: SRP500553
Created: 2024
primary tissue
compound
zone of skin
graft versus host disease
Public Data
24 samples
The pan-RAF-MEK non degrading molecular glue NST-628 is a potent and brain penetrant inhibitor of the RAS-MAPK pathway with activity across diverse RAS- and RAF-driven cancers
Accession: SRP495053
Created: 2024
cell line
compound, control
melanoma
Public Data
24 samples
TRAF3 loss-of-function Reveals the Non-Canonical NF-?B Pathway as a Therapeutic Target in Diffuse Large B-cell Lymphoma
Accession: SRP409782
Created: 2024
cell line
lymph node
diffuse large B-cell lymphoma
Public Data
6 samples
GEO accession GSE200646 is currently private and is scheduled to be released on Apr 12, 2024.
Accession: SRP369684
Created: 2024
cell line
overexpression
gastric cancer
Public Data
2 samples
GEO accession GSE245548 is currently private and is scheduled to be released on Oct 16, 2027.
Accession: SRP466805
Created: 2024
cell line
control, sirna
kidney
Public Data
16 samples
GEO accession GSE207452 is currently private and is scheduled to be released on Jun 19, 2025.
Accession: SRP384895
Created: 2024
xenograft
sirna
glioblastoma
Public Data
44 samples
Identification of unique gene expression and splicing events in early-onset colorectal cancer
Accession: SRP479528
Created: 2024
primary tissue
caecum, descending colon, ...
colorectal cancer